Nephrogen Alternatives & Competitors
12 companies similar to Nephrogen — Curative gene therapies for kidney diseases
Helex
Genomic medicines for kidney diseases with high unmet need
New York, United States
Walden Biosciences
Transforming the Treatment of Kidney Disease
Cambridge, United States
Pathalys Pharma
Our mission is to improve the lives of patients through enhanced therapeutics to advance t...
Raleigh, United States
Purespring Therapeutics
We are Purespring. We are on a mission to radically transform the treatment of kidney dis...
London, United Kingdom
Track all Nephrogen competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Verge Genomics
Better drugs, faster. For patients who can’t wait.
South San Francisco, Unit...
Nuvamid
A clinical stage biotech focused on the research and use of nucleotides, as therapeutics f...
Nyon, Switzerland
Mammoth Biosciences
Improving lives by reading and writing the code of life.
Brisbane, United States
Mogrify
Transforming the lives of patients with degenerative diseases through a novel class of in...
Cambridge, United Kingdom
Harness Therapeutics
Unlocking New Targets to Transform the Treatment of Neurodegenerative Diseases
Cambridge, United Kingdom
Tridek-One
We develop first-in-class CD31 checkpoint agonists for the treatment of auto-immune diseas...
Paris, France
Entelexo Biotherapeutics
Entelexo has created a novel platform technology for engineering exosomes as a new approac...
Irvine, United States
Gandeeva Therapeutics
Gandeeva Therapeutics uses the most advanced cryo-EM and computational tools to develop be...
Canada
About Nephrogen
Curative gene therapies for kidney diseases
Development of curative genomic medicines, AI-driven gene delivery platform, High-throughput in vivo screening, Research and development in gene therapy
Patients with kidney and pancreatic diseases, Medical professionals in nephrology, Biotech and pharmaceutical companies, Healthcare providers
Biotech, Gene Therapy, Kidney Diseases, Polycystic Kidney Disease, PKD Treatment, Curative Therapies, Biopharmaceuticals, Genomic Medicine, Disease-specific Therapy, Therapeutic Development, Medical Research, Clinical Biotechnology
B2B, B2B2C, Platform
Product Sales, Licensing, Value Based Pricing
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Nephrogen and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Nephrogen on 7 Apr 2026. The 12 companies listed here were last checked between 25 Mar 2025 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.